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Abstract
Background: Although a substantial decline of Plasmodium falciparum infection is observed in Africa following
implementation of new control strategies, malaria is still considered as the major cause of febrile illness in
hospitalized African children. The present study was designed to assess the management of febrile illness and to
determine the proportion of children with febrile illness hospitalized for primary diagnosis of malaria who had
confirmed complicated malaria after implementation of new malaria control strategies in Libreville, Gabon.
Methods: Demographic, clinical and biological data from hospitalized children with fever or a history of fever,
with a primary diagnosis of clinical malaria, aged less than 18 years old, who benefited from hematological
measurements and microscopic malaria diagnosis, were recorded and analyzed during a prospective and
observational study conducted in 2008 in the Centre Hospitalier de Libreville.
Results: A total of 418 febrile children were admitted at hospital as malaria cases. Majority of them (79.4%) were
aged below five years. After medical examination, 168 were diagnosed and treated as clinical malaria and, among
them, only 56.7% (n = 95) had Plasmodium falciparum positive blood smears. Age above five years, pallor, Blantyre
Coma Score ≤2 and thrombocytopenia were predictive of malaria infection. Respiratory tract infections were the
first leading cause of hospitalization (41.1%), followed by malaria (22.7%); co-morbidities were frequent (22%). Less
than 5% of suspected bacterial infections were confirmed by culture. Global case fatality rate was 2.1% and 1% for
malaria. Almost half (46%) of the children who received antimalarial therapy had negative blood smears. Likewise,
antibiotics were frequently prescribed without bacteriological confirmation.
Conclusions: The use of clinical symptoms for the management of children febrile illness is frequent in Gabon.
Information, training of health workers and strengthening of diagnosis tools are necessary to improve febrile
children care.
Background
In Africa, one in six children dies before its fifth birthday
from treatable conditions such as pneumonia, gastro-
enteritis and malaria [1]. In 2009, the World Health
Organization (WHO) estimated that among the 761,000
deaths attributable to malaria, more than 80% occurred in
African children less than five years old [2]. During
recent decades, malaria has become a default diagnosis
for acute febrile illness in many African settings though is
presently declining [3]. Moreover, clinical manifestations
of complicated forms of malaria, which include mainly
cerebral malaria and severe anemia, usually overlap those
of other severe febrile illness in endemic countries.
Presumptive treatment of fever was recommended by
WHO for a long time. However, such a strategy is no
longer satisfactory because of its poor specificity, leaving
non-malarial febrile patients without an appropriate
treatment. In fact, evidence suggests a higher mortality
in children diagnosed and treated for malaria without
microscopic confirmation compared to those who bene-
fited from microscopically confirmed malaria [4]. The
biological diagnosis of malaria is still not routinely done
by health staff from many endemic countries, even when
it is available [5]. In Gabon, where a substantial decline
of malaria prevalence in Libreville, the capital city, has
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been observed, little is known about the suitability of
treatment of patients in the pediatric wards in public
hospitals |5]. Indeed, a threefold reduction of malaria
cases was observed in the country [6,7]. A shift toward a
higher susceptibility of children older than five years was
also noted for uncomplicated malaria, suggesting an epi-
demiological transition of the infection in the country.
The frequency of complicated malaria should also be
influenced by interventions. Therefore, the decline of
malaria prevalence can also result in a parallel decrease
of, or influence the frequency of cerebral malaria (CM)
and severe malarial anaemia (SMA) as reported in
north-eastern Tanzania and in rural Kenya [8,9].
The aim of the present study was to assess the man-
agement of febrile illness and to determine the propor-
tion of children with febrile illness hospitalized for
primary diagnosis of malaria who had confirmed compli-
cated malaria, at the Centre Hospitalier de Libreville, the
main public health centre of Gabon, after implementa-
tion of new malaria control strategies.
Methods
Study site
The survey took place in Libreville, the capital city of
Gabon where more than 40% of the population lives. In
this urban area, the climate is equatorial; malaria preva-
lence among febrile children was 15% in 2008, predom-
inantly caused by P.falciparum. Annual entomological
inoculation rate is 33.9 and Anopheles gambiae s.s. is the
main vector [10]. The Centre Hospitalier de Libreville
(CHL) is the largest public hospital of Gabon; it has two
pediatric wards where patients aged between 30 days
and 17 years old are admitted. During the study period,
due to the closing of the second ward (22 beds) for its
rebuilding, the recruitment was performed in the main
pediatric ward which has a capacity of 35 beds with
about 1440 hospitalized children per year. The clinical
care of these patients is performed by medical doctors
and pediatricians. Children are visited daily by one of
the medical staff member.
The Malaria Clinical and Operational Research Unit
(MCORU) is a branch of the Department of Parasitology
of the Medicine Faculty, located in the CHL. In this unit,
all febrile in and out-patients from the pediatric and
emergency wards routinely benefit from free malaria
diagnosis based on microscopic examination.
Study design
This was a prospective and observational pilot study car-
ried out from June to December 2008, in Libreville. This
period covers the dry and the rainy seasons, as well as
the period at which the maximum number of consulta-
tions is observed at the CHL, i.e. after returning from
holidays from remote areas, at the time of the start of
the new school year.
Data from children aged less than 18 years old, with
fever (rectal temperature ≥ 38.0°C) or a history of
fever during the 24 hours preceding the consultation,
hospitalized for primary diagnosis of clinical malaria,
who benefited from hematological measurements and
P. falciparum microscopic detection, were prospectively
collected and analyzed.
Data collection
Oral consent was obtained from parents or guardians in
order to complete the demographic and medical history
sections on a case report form (CRF) by questioning the
parents if necessary. Recorded demographical data were
date of birth, residence, marital and employment status
of the parents or tutors. The medical history section
comprised the following: previous malaria, drug intake,
blood transfusion, vaccination status, use of bednet,
asthma, confirmed sickle cell trait, duration of illness.
The clinical data collected for the current disease were
the symptoms leading to the consultation; the physical
examination included the assessment of weight, general
physical state, rectal temperature, respiratory frequency,
mucosal coloration, nutritional (weight for age z-score)
and hydration status. The nutritional status was classi-
fied as follows: children with a Z score > -2 were classi-
fied as normal nourished, children with a Z score <−2
and > = −3 as moderately malnourished, and children
with a Z score <−3 as severely malnourished. Additional
investigations, based on clinical symptoms and blood
count if judged necessary by physicians, were chest radi-
ography, cerebro-spinal fluid (CSF), stool and sputum
analysis, blood, CSF and urine culture, HIV-antibody de-
tection, tuberculin intra-dermal reaction.
Based on various criteria, the following diagnosis were
defined: malaria (fever with positive blood slide), sus-
pected lower respiratory tract infection (fever associated
with respiratory symptoms and abnormal X-rays), menin-
gitis (fever with neurological symptoms and abnormal
CSF if analysis performed), urinary infection (fever in
presence of suprapubic pain and pathogen identified
in urine culture when performed), gastroenteritis (fever
with vomiting and diarrhea), pulmonary tuberculosis (sus-
pected low respiratory tract infection and positive expec-
toration associated with a positive intradermal reaction).
Laboratory investigations allowed the definition and clas-
sification of hyperparasitemia if parasite count >250,000/
μL; of anaemia classified as severe if Hb<5.0 g/dL, moder-
ate if 5.0 <Hb<8.0 g/dL and low if 8.0≥Hb<10.9 g/dL;
of leucocytosis defined by taking into account the rate
of leucocytes according to the age; of thrombocytopenia
when platelet count was below 150.103/μL.
Bouyou-Akotet et al. BMC Infectious Diseases 2012, 12:216 Page 2 of 9
http://www.biomedcentral.com/1471-2334/12/216
Treatments
The therapeutic management was recorded as well as
the clinical evolution on the CRF. All children enrolled
were hospitalized and malaria was treated with intraven-
ous quinine (25 mg/kg/day,) followed by oral quinine
when patient was able to swallow. Febrile children
received intravenous paracetamol or suppositories (60 mg/
kg/day). Seizures were controlled with diazepam, severe
anaemia and not tolerated moderate anaemia were
corrected by transfusion of packed red cells. Other
treatments were intravenous fluid for severe dehydration,
antibiotics for suspected bacterial infections, nasal
oxygen at 6 L/minute for respiratory distress.
Consideration
The study was approved by the public health ministry of
Gabon. Study aims were clearly explained to the paediat-
ric ward staff. Children's parents or guardians were
informed about the protocol, and their oral consent was
required prior to data collection. Although it was a non
invasive study, this oral consent was sought from the
parents/guardians in order to obtain medical history and
to use the demographic, clinical and biological data and
other results of other investigations that were reported
on the CRF. Data were kept as confidential.
Statistical analysis
All data were entered and cleaned using Epi-info version
3.3.2 (2005 CDC Atlanta).
Variables were summarized as frequencies and percen-
tages, means and standard deviation, or medians and
interquartile ranges, as appropriate. They were com-
pared with the use of the chi-square test, Anova, or
non-parametric tests as appropriate. Median with inter-
quartile ranges was used for age and parasitaemia. We
performed logistic regression to assess the effect of
various confounding factors and potential determi-
nants P.falciparum malaria. Analysis resulting in
values of p < 0.05 were considered significant. All
reported p-values are two-tailed.
Results
Study population
During the year 2008, 4684 children were screened at
the MCORU, 2521 were hospitalized in the different
wards. From June to December, 804 patients were admit-
ted in the pediatric ward, 431 febrile of them were
considered as malaria cases and benefitted from both
malaria diagnosis and haematological count. Thirteen
(3.0%) patients were excluded from the analysis due to
missing data on the CRF. Among the remaining patients,
235 were referred by the outpatient unit and 183 came
from the emergency ward. The median age of patients
was 24 [12–48] months; the youngest was one month
and the oldest 192 months. Age was distributed as fol-
lows: <6 months (n = 44, 10.5%), 6 to 18 months
(n = 147, 35.2%), 19 to 36 months (n = 110, 26.3%), 37–
59 months (n = 31, 7.4%), 60–120 months (n = 66, 15.8%)
and above 120 months (n = 20; 4.8%). More than half of
the children (n = 257; 61.5%) were aged 6 to 36 months.
The sex ratio was 1.2.
Medical history and clinical data
All patients were referred with a primary diagnosis of
malaria; 38 (9.1%) were sickle cell trait carriers and 32
(7.6%) had a history of asthma. One third (n = 138; 33%)
of patients were not well vaccinated according to the
Enlarged Program of Immunization and 66.5% (n = 278)
used bednets. Main reasons, for consultation aside
from fever or history of fever, were asthenia, abdominal
symptoms, cough and seizures (Table 1). Five (1.2%)
children were admitted with a BCS below 2. Less than
10% (n = 27) and 32% (n = 134) of children were admi-
nistrated antibiotic or antimalarial drugs before con-
sultation, respectively.
Median temperature was 38.9°C, and pallor was
observed in half of the patients (51%; n = 211) (Table 1).
Malnutrition, either moderate (n = 26) or severe (n = 15),
concerned 41 (9.8%) patients. Frequency of severe mal-
nutrition was of 8.8% (n = 13/147) among children aged
between six and 18 months.
Thick smears and hematological analysis were system-
atically performed for hospitalized patients, X-rays were
frequently prescribed (n = 299, 71.5%), whereas CSF and
urine analysis, as well as stools and blood cultures, were
realized for 4.5% (n = 19), 2.6% (n = 11), 1.7% (n = 7)
and 3.1% (n = 13) of patients respectively. Tuberculin
intra-dermal reaction and HIV testing were requested
for 54 (12.9%) and 29 (6.9%) patients respectively.
After all investigations, lower respiratory tract infec-
tion (n = 172, 41.1%), malaria (n = 168, 40.2%), gastro
enteritis (n = 74, 17.7%) and meningitis (n = 16, 3.8%)
were the main recorded final diagnosis (Table 1 and
Figure 1). Pulmonary tuberculosis was diagnosed in 16
(9.3%) patients. HIV infection was detected in nine
patients. Bacterial gastro-enteritis was confirmed in five
patients, due to Escherichia coli (n = 4) and Shigella
(n = 1). Among the 168 patients with a final diagnosis of
clinical malaria, 56.6% (n= 95) had confirmed P.falcip-
arum infection with almost in a quarter (24.2%) another
infection, mainly suspected lower respiratory tract infec-
tion (Figure 1). This later was also frequent among the
73 (43.4%) patients with a negative blood smear. Around
ten percent (n = 44) of patients left the ward without an
etiological diagnosis.
Anaemia was found in 355 (84.9%) children: 44
(10.5%) with severe anaemia and 114 (27.3%) with mod-
erate anaemia. Malnutrition and respiratory distress
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were not associated with severe anaemia (p= 0.3). How-
ever, all patients with sickle cell disease had Hb level
below 11 g/dL and were at higher risk of severe anaemia
(29% versus 8.7% with normal hemoglobin; OR: 4.4[2.01-
9.7] (p < 0.01)).
Malaria patients
Approximately 23% (n = 95/418) of the participants had
confirmed P.falciparum infection. They were signifi-
cantly older (48 months) than those without malaria
(18 months) (Table 2). The risk of having malaria was
the highest between 37 and 120 months (aOR: 13.7[3.3-
37.8] p < 0.01). Bednet use was associated with a reduced
risk of malaria (17.0% versus 34.1%) (Table 3).
At admission, infected patients presented more fre-
quently with pallor (n = 66, 69.5%), convulsions (n = 25,
26.3%), vomiting (n = 22, 23.2%) and prostration (n = 18,
18.9%). Overall, 20 (21.1%) patients had severe malaria
(SM) according to the WHO classification: two had CM,
four presented a syndrom of respiratory distress and 14
(14.7% of malaria patients) with SMA. More than three
quarters of SM patients (n = 11) were aged between 6 to
36 months old and the two children with CM were 48
and 60 months old respectively. Pallor and presence of
neurological symptoms were associated with a higher
risk of being infected (Table 3). Seizures were noticed
more frequently in parasitaemic children (27.3% versus
10.2% in uninfected ones; OR: 3.3[1.8-5.9], p < 0.01).
The parasite density ranged from 700 to 622,000 p/μL
with a median of 22,500[5,000-70,700]p/μL. Hyperpara-
sitaemia was found in five children aged between 16
and 48 months. Most of the parasitemic patients were
anaemic (90.5%) and the median Hb level was the lowest
in the malaria group compared to the uninfected one.
The same trend was observed with platelet count
(Table 2). Anemia and thrombocytopenia were asso-
ciated with a higher risk of having a malaria-positive
blood slide (p < 0.01) (Table 3). The frequency of moder-
ate and severe anemia was highest in infected patients
(respectively 52.6% and 14.7%) compared to non malaria
patients (respectively 34.5% and 10.5%) (p < 0.01). None
of the HIV positive patients had malarial infection and
only two children with malnutrition were infected.
Treatment
Drug prescription
Approximately two thirds of patients (n = 261) were trea-
ted with antibiotics, only 115 having leucocytosis. Quin-
ine was administered to 42.1% (n = 176) of patients, 81
(46.0%) of them were malaria blood slide negative. One
patient without clinical and or biological malaria diagno-
sis was also treated with an antimalarial drug (Table 4).
Among the 73 patients who benefited from antibiotic
plus antimalarial treatment, 21 (28.8%) had a confirmed
co-morbidity.
Blood transfusion
A blood transfusion was given to 96 (27.0%) anaemic
children: 41 had severe anemia and 55 had moderate
anemia, their Hb level varied from 5.0 g/dL to 7.9 g/dL.
Three patients with severe anemia were not transfused.
Case fatality rate
Of the 418 patients, nine died, giving an overall case
fatality rate of 2.1%. They were hospitalized for respiratory
tract infection (n=5), gastro-enteritis (n =2), meningitis
Table 1 Hospital recorded diagnosis based on patient
clinical features
Characteristics Median Interquartile
rangeAll admissions (n = 418)
Age in months, 24.0 [12–48]
Duration of illness in days 3.0 [2–5]




Main reasons for consultation
Asthenia 193 (46)
Repeated vomiting 151 (36)
Diarrhoea 120 (29)




Blantyre Coma Score < 5 62 (15)
Diagnosis of lower respiratory tract infectiona (n = 172/418)
Cough 91 (53)
Rattling 79 (46)
Deep breathing 14 (8)
Pneumonia syndrome 40 (23)
Abnormal x-ray 151 (88)




Diagnosis of meningitisa (n = 16/418)
Vomiting 6 (38)
BCS≤ 4 8 (50)
Seizures 7 (44)
Neck stiffness 7 (44)
Abnormal CSFb 5/7 (71)
a: cases can appears in many categories; b: cerebro-spinald fluid.
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(n = 1) and malaria (n= 1). The case fatality rate for mal-
aria was therefore of 1.0%; this patient presented respira-
tory distress and CM.
Death was associated with a higher median duration of
illness before consultation, 7 [4.8-7.3] days versus 3 [2.0-
5.0] days in the group of survivors (p < 0.01); and with a
lower median age: 12 [3.0-14.5] months versus 24[12.0-
48.0] months (p < 0.01). Six children were aged between
12 and 36 months and three were less than six months
old. Case fatality rate among the less than five years old
children was 2.7%.
Discussion
Presumptive treatment of fever with antimalarial drugs
is still frequent in public health settings of sub-Saharan
Africa, even in countries where ACTs, bed nets, malaria
diagnosis and IPT are freely provided to vulnerable
population [8]. During the last years, the prevalence of
fever due to malaria has been drastically reduced in sev-
eral countries including Gabon [3,6]. There is an urgent
need to better manage febrile illness, especially in
children, to avoid high mortality due to misdiagnosis of
other etiologies, and overtreatment of non confirmed
malaria cases which leads to impairment of patient out-
comes, waste of money and time, and increased risk of
drug resistance [4,11]. Unfortunately, clinical diagnosis
through the syndromic approach, according to the inte-
grated management of children febrile illnesses, remains
the main method for the diagnosis [11-13].
In Libreville, malaria declined from being the primary
cause of hospitalization among febrile children admitted
in the same pediatric ward in 2002, to representing the
second cause six years later [14].
Hospital case management of seriously ill children is a
challenge in middle and low income countries, mostly
due to few resources for diagnosis and treatment, staff
availability, and laboratory services [13,15]. Respiratory
tract infections, gastro-enteritis, urinary infections and
meningitis are the main evocated etiologies of severe
febrile illness in hospitalized children either in west, east,
central Africa and Asia [11,16-18]. Symptoms of these
conditions always overlap with malaria, leading to
Figure 1 Distribution of main fever-attributable etiologies among children admitted for primary diagnosis of malaria.
Table 2 Relationship between studied variables* and P.falciparum infection
Malaria slide-positive patients (N= 95) Malaria slide-negative patients (N= 73) p-value
Age, months 48 [24–72] 18 [9–36] <0.01
Duration of illness, days 3 [2–4] 4 [2–6] <0.01
Temperature, °C 39.0 [38.5-39.8] 38.8 [38–39] <0.01
Laboratory parameters
- Hb, g/dL 7.7 [5.8-9.7] 9.5 [7.3-10.5] <0.01
- Leucocytes, 103/μL 9.9 [7.1-12] 12.0 [8.7-18.0] <0.01
- Platelets count, 103/μL 89.0 [51.0-122.0] 298.0 [165.0-417.0] <0.01
*: medians with interquartile ranges are presented.
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difficult patient management, misuse of antibiotics and
antimalarial and higher mortality rates [19,20]. Less than
one quarter of children had co-morbidities, mostly mal-
aria and lower respiratory tract infection, as reported
in Kenya and Uganda [12,21]. Bacteremia was not
confirmed when suspected in children included, al-
though bacteria are the most frequently associated
pathogens to P.falciparum infection, either through
infection or co-incidental parasitaemia [20-22]. Beside
bacteria, HIV infection and malnutrition are also
frequent and responsible of life threatening conditions in
malaria infected patients [22,23], this is not the case in
the present study. Likewise, between 2005 and 2007, an
increase rate of non-malarial and non-bacteremia fevers
has been observed, with appearance of Chikungunya and
Dengue infections, among other viral infections in
Libreville [24]. Approximately half of the patients treated
with antimalarial were blood smear negative, suggesting
another undiagnosed cause of fever and the necessity of
an improvement of clinical and laboratory diagnosis as
Table 3 Logistic regression analysis of factors associated with risk of complicated malaria
Variables Malaria ORa [95%CI]b p aORc [95%CI] p
Prevalence
Age
-≥ 5 years (n = 86) 32 (37.2%) 2.6[1.5-4.3] <0.01 2.5[1.3-4.7] <0.01
- < 5 years (n = 332) 63 (19.0%) 1
Bed net
- users (n = 276) 47 (17.0%) 0.4[0.2-0.6] <0.01 0.4[0.2-0.7] <0.01
- non users (n = 129 44 (34.1%) 1
Drug intake
-Yesd (n = 95) 41 (43.2%) 0.5[0.3-0.8] <0.01 1.3[0.8-2.3] 0.3
-Nod (n = 323) 93 (28.8%) 1
Pallor
-Yes (n = 95) 66 (69.5%) 2.8[1.7-4.0] <0.01 2.9[1.7-5.2] <0.01
-No (n = 321) 143 (44.5%) 1
Prostration
-Yes (n = 95) 18 (18.9%) 2.3[1.2-4.3] <0.01 3.6[0.0-40.8] 0.3
-No (n = 323) 30 (9.3%) 1
Neurological symptomsf
-Yes (n = 95) 39 (41.0%) 3.2[1.9-5.2] <0.01 3.4[1.9-6.3] <0.01
-No (n = 323) 60 (18.6%) 1
Anaemia
-Yes (n = 95) 86 (90.5%) 3.2[1.3-7.7] <0.01 3.3[1.6-7.9] <0.01
-No (n = 323) 269 (83.3%) 1
Severe anaemia
-Yes (n = 95) 14 (14.7%) 1.7[0.8-3.3] <0.13 1.8[0.8-4.2] 0.1
-No (n = 323) 30 (9.3%) 1
BCS≤ 2
-Yes (n = 95) 2 (2.1%) — —
-No (n = 323) 0 (0.0%° – —
Thrombopenia
-Yes (n = 95) 80 (84.2%) 19.6[10.6-36.2] <0.01 2.6[1.3-5.3] <0.01
-No (n = 323) 69 (21.4%) 1
VOCg
-Yes (n = 95) 2 (2.1%) 0.2[0.02-0.7] <0.01 0.1[0.0-0.5] <0.01
-No (n = 323) 35 (10.8%) 1
a: crude odds ratio; b: 95% confidence interval; c: adjusted odds ratio d: malaria infected patients; e: non infected patients;
f: see detailed symptoms in Table 1, g : vaso-occlusive crisis in patients with sickle cell disease.
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well as training and supervision of health workers for a
proper case management.
Globally, prostration, neurological symptoms like sei-
zures and pallor are the main clinical forms of malaria
among children with acute febrile illness as observed in
other endemic countries [25,26]. Thrombocytopenia and
low Hb level, both predictors of malaria, have also been
found to be associated to a greater risk of being infected
[27,28]. The increase of the frequency of Plasmodium
infections with age observed since 2006 in outpatients
was confirmed among the inpatients: children older than
five years are 2.6 times more at risk for having compli-
cated malaria. This suggests a change in the transmission
profile of the disease as the prevalence of infection
increases with age with decreasing transmission [26,29,30].
The median age of children with complicated malaria was
48 months compared to the non-infected (18 months).
Moreover, cerebral malaria (CM), which has been shown
to increase with age when the intensity of the transmission
decreases, was observed in children aged more than
48 months old [30]. This was not the case six years earlier
when 65% of CM was confined to children aged between
12 and 48 months. A recent meta-analysis showed that in
areas with no seasonality, the median age of cases with
CM increases with lowering transmission intensity (from
29 months in medium intensity areas to 49 months in low
intensity areas), whereas the median age of cases of severe
malarial anemia (SMA) did not significantly vary and
remains concentrated among younger children [30]. In
2008, 75% of children with SMA were between 6 to
36 months old, and, in 2002, they were below 24 months
[14]. The high burden of anemia (85%) and its multifactor-
ial etiology are likely to be the reasons for the fact that
SMA is the major clinical presentation of severe malaria
(SM); it would therefore be difficult to use anaemia as
marker for malaria transmission intensity characterization
[11,30,31]. Indeed, despite the decline of complicated mal-
aria prevalence observed in this study, the frequency of se-
vere anemia has not drastically changed compared to
2001–2002 (9.4% in 2001–2002 and 10.5% in 2008),
as well as that of SMA (14.3% in 2001–2002 and
14.7% in 2008) in Libreville [32]. This observation
raises the problem of the complex aetiology of an-
aemia; moreover, it seems that P.falciparum infection
often occurs in patients with chronic anaemia and
increases its gravity [33].
Improvement of medical care is ongoing in Gabon, but
most of the population cannot benefit from complemen-
tary examinations because of poor financial resources and
lack of equipment at health centers. As an example, be-
side chest X-ray that is systematically prescribed in case
of suspected respiratory tract infection, lactate levels can-
not be measured at the CHL and material for blood and
CSF cultures is always lacking. Therefore, it remains cru-
cial to use clinical and biological signs to target malaria
infected children for a rational use of antimalarial drugs
in poor resource areas. Pallor, presence of neurological
symptoms, BCS ≤ 2 and age >5 years, were predictors of
malaria infection among children hospitalized for fever.
These risk factors have also been found in children from
other countries [16,34,35]. As always reported, Hb level
below 8 g/dL and severe anemia are biological risk fac-
tors, thrombocytopenia also being a prognosis factor in
children with parasitemia [28,35]. Other factors associated
with poor outcome in SM children are low BCS, co-infec-
tion, HIV, bacteremia, hyperlactatemia, malnutrition and
respiratory distress [10,20,34,36]. Children who died from
SM had respiratory distress and CM, two clinical forms
already reported as prognosis factors at Libreville in 2002.
Even if malaria diagnosis and hematological count were
freely provided to patients, overdiagnosis (43%) and over-
treatment with antimalarial drugs (46%) were common.
Although the low number of P.falciparum-infected
patients, lethality was lower (1%) compared to that
observed between 2001–2002 in the same paediatric
ward (9%) and in 11 African countries (10.5%); probably
due to i) the reduced cases of malaria, ii) a better case
management because all malaria cases were microscop-
ically confirmed and suspected co-morbidities treated
with both antimalarial and antibiotics [37,38].
After the deployment of new preventive measures,
decreased frequency of malaria hospital admissions and
its various clinical presentations were observed [9].
However, despite an adequate coverage, the reduction of
the malaria burden observed among children or preg-
nant women, during the first years of the deployment,
was followed with either stabilization or, conversely, an
increase in the frequency of P.falciparum infection [39-41].
Table 4 Drug prescription for patients (n = 418) with positive or negative slides at CHL
Drugs Other diagnosis
(n = 250)
Clinical diagnosis of malaria (n = 168) Total
(N= 418)Slide (+)ve (n = 95) Slide (−)ve (n = 73)
Antimalarial, n (%) 1 (0.4) 59 (62.1) 43 (58.9) 103 (24.6)
Antibiotic, n (%) 188 (75.2) 0 (0.0) 0 (0.0) 188 (44.9)
Antibiotic +Antimalarial 9 (3.6) 36 (37.9) 28 (38.4) 73 (17.5)
Other, n (%) 52 (20.8) 0 (0.0) 2 (2.7) 52 (20.8)
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The protective effect of these control strategies, confirmed
here with the lower prevalence of malaria among bednet
users, is well recognized. Regular monitoring should abso-
lutely be implemented in Gabon where ITNs, ACTs and
diagnostic tools coverage is still weak or lacking in the
health centers from remote and peripheral areas.
This pilot study allowed the inclusion of an enough
number of patients to provide reliable data on hospita-
lized febrile children. A higher number of inclusions
would have probably not given more indications on
febrile illness management in the paediatric ward, nei-
ther more clinical data. Indeed, the main limit of this
study concerns the lack of additional investigations ne-
cessary to finalize the diagnosis. They are most of the
time not performed because of poor financial resources
of the parents. Furthermore, there are some limitations
on using health facility–based data including the lack of
a knowledge on variations in access to, or use of the fa-
cilities in the community, extend of real coverage by
various interventions.
Nevertheless, hospital based studies provide accurate
data on children febrile illness etiologies, though they
cannot replace epidemiological surveys in the commu-
nity [42]. The present data can be used for the
characterization of the malaria epidemiology over time
in a specific area. However, local data are needed for
WHO guidance application and are lacking in several
endemic countries, including Gabon.
Conclusion
This study, and the one performed between 2001 and
2002, highlights the most likely causes of fever as well as
a reduction in the frequency of P.falciparum infection
in Gabon in 2008. These results can help for the design
of an effective development of new guidelines for fever
case management. Priority areas to achieve proper
patient care are quality of diagnosis, treatment practices,
availability of biological and radiographic diagnosis tools,
introduction of malaria diagnosis RDTs to discriminate
malarial to non malarial fevers and bring out rational
use of drugs, health worker training and adherence
to guidelines.
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